Author

J. Gallant

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:mouse· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:electrophysiology· 1

Frequent Co-Authors

A. Drelich· 1 shared A. Ghezzi· 1 shared A. LeBeau· 1 shared A. Odle· 1 shared C. Cai· 1 shared C. Massey· 1 shared C.-T. Tseng· 1 shared D. B. Halling· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Drelich

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders

S. A. Raithatha, J. M. Hagel, K. Matinkhoo, L. Yu, D. Press, S. G. Cook, G. Sharma, D. Dhananjaya, G. Jensen, J. B. Lee, C. Cai, J. Gallant, J. S. Bains, J. E. Tucker, P. J. Facchini

This paper identifies novel psilocin prodrugs with altered pharmacokinetics and reduced psychedelic effects, maintaining therapeutic benefits for anxiety disorders.

bioRxiv · May 16, 2023Pharmacology & Toxicology

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

G. Ye, J. Gallant, C. Massey, K. Shi, W. Tai, J. Zheng, A. Odle, M. Vickers, J. Shang, Y. Wan, A. Drelich, K. Kempaiah, V. Tat, S. Perlman, L. Du, , F. Li

This paper develops a potent, low-cost nanobody therapeutic, Nanosota-1C-Fc, that effectively blocks SARS-CoV-2 infection in vitro and in vivo with high affinity and stability.

bioRxiv · Nov 17, 2020Microbiology

Electrostatic Tuning of a Potassium Channel in Electric Fish

I. Swapna, A. Ghezzi, M. R. Markham, D. B. Halling, Y. Lu, J. Gallant, H. Zakon

The paper identifies a voltage-gated potassium channel in African mormyrid electric fish that evolves under positive selection and modifies action potential duration through unique biophysical properties.

bioRxiv · Oct 19, 2017Evolutionary Biology